Biopharmaceutical investors
7 investors that name Biopharmaceutical among their sectors are recorded here: 3 venture capital firms, 2 other investors, 1 asset manager and 1 private equity firm. Stated investment stages run from pre-seed to buyout. Most are headquartered in the United States (4) and France (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| 7G BioVentures life science · biopharmaceutical · biotechnology · ophthalmic |
Direct investor | Venture capital | Not stated | Burlingame, United States |
| Avoro Capital Advisors LLC biotechnology · life sciences · biopharmaceutical |
Direct investor | Asset manager | Pre-seed – Growth | New York, United States |
| Care Equity Capital Management, L.P. drug discovery · drug development services · biopharmaceutical |
Direct investor | Other | Not stated | New York, United States |
| Checkpoint Capital L.P. biopharmaceutical |
Direct investor | Other | Not stated | |
| Leonarto VC Spółka Akcyjna technology · medical solutions · biopharmaceutical · nanotechnology |
Direct investor | Venture capital | Not stated | |
| Mérieux Equity Partners healthcare · medtech · biopharmaceutical |
Direct investor | Private equity | Seed – Buyout | Paris, France |
| Petrichor healthcare · biopharmaceutical · medical technology · diagnostics |
Direct investor | Venture capital | Pre-seed – Growth | New York, United States |